Education
About Us
Working with TipRanks
Follow Us
Establishment Labs Holdings Inc (ESTA)
NASDAQ:ESTA
ESTA Stock Chart & Stats
Day’s Range― - ―
52-Week Range$26.56 - $50.85
Previous CloseN/A
Volume125.18K
Average Volume (3M)419.82K
Market Cap
$1.11B
Enterprise Value$1.41B
Total Cash (Recent Filing)$69.18M
Total Debt (Recent Filing)$225.70M
Price to Earnings (P/E)―
Beta1.23
Next Earnings
Nov 11, 2025EPS Estimate
-0.51Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-0.57
Shares Outstanding28,970,736
10 Day Avg. Volume638,579
30 Day Avg. Volume419,825
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
P/FCF RatioN/A
Enterprise Value/Market Cap1.27
Enterprise Value/Revenue8.29
Enterprise Value/Gross Profit12.50
Enterprise Value/Ebitda-24.49
Forecast
1Y Price Target
$55.13Price Target Upside41.03% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering8
Bulls Say, Bears Say
Bulls Say
Market ExpansionESTA's innovative portfolio featuring best-in-class data and leveraging multiple demand trends is poised to take considerable share in the US market as its domestic launch continues and as it submits more of its products/indications to the FDA.
Product InnovationInnovating by spearheading minimally invasive surgical aesthetics: ESTA’s most recent procedural innovations, Mia and Preservé, facilitate minimally invasive breast implantations.
Revenue GrowthRevenue growth improved to 16% from 11%, and US sales grew approximately 70% sequentially, beating consensus.
Bears Say
EBITDA Margin DeclineAdjusted EBITDA margin decreased by 740 basis points year over year due to spending on the US launch.
Increased SpendingManagement raised their 2025 revenue guidance modestly driven by increased US guidance.
Sales DeclineSales declined year-over-year in AsiaPac largely due to the China distributor order comp.
Establishment Labs Holdings News
ESTA FAQ
What was Establishment Labs Holdings Inc’s price range in the past 12 months?
Establishment Labs Holdings Inc lowest stock price was $26.55 and its highest was $50.85 in the past 12 months.
What is Establishment Labs Holdings Inc’s market cap?
Establishment Labs Holdings Inc’s market cap is $1.11B.
When is Establishment Labs Holdings Inc’s upcoming earnings report date?
Establishment Labs Holdings Inc’s upcoming earnings report date is Nov 11, 2025 which is in 81 days.
How were Establishment Labs Holdings Inc’s earnings last quarter?
Establishment Labs Holdings Inc released its earnings results on Aug 07, 2025. The company reported -$0.57 earnings per share for the quarter, missing the consensus estimate of -$0.532 by -$0.038.
Is Establishment Labs Holdings Inc overvalued?
According to Wall Street analysts Establishment Labs Holdings Inc’s price is currently Undervalued.
Does Establishment Labs Holdings Inc pay dividends?
Establishment Labs Holdings Inc does not currently pay dividends.
What is Establishment Labs Holdings Inc’s EPS estimate?
Establishment Labs Holdings Inc’s EPS estimate is -0.51.
How many shares outstanding does Establishment Labs Holdings Inc have?
Establishment Labs Holdings Inc has 28,970,736 shares outstanding.
What happened to Establishment Labs Holdings Inc’s price movement after its last earnings report?
Establishment Labs Holdings Inc reported an EPS of -$0.57 in its last earnings report, missing expectations of -$0.532. Following the earnings report the stock price went down -13.951%.
Which hedge fund is a major shareholder of Establishment Labs Holdings Inc?
Currently, no hedge funds are holding shares in ESTA
Establishment Labs Holdings Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$55.13 (41.03% Upside)
$55.13 (41.03% Upside)
Blogger Sentiment
Bullish
ESTA Sentiment 100%
Sector Average 71%
Sector Average 71%
Hedge Fund Trend
Increased
By 650.3K Shares
Last Quarter.
Last Quarter.
Insider Transactions
Sold Shares
Worth $152.9K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Negative
Last 7 Days ▼ 5.6%
Last 30 Days ▼ 4.9%
Last 30 Days ▼ 4.9%
News Sentiment
Neutral
Bullish news 50%
Bearish news 100%
Bearish news 100%
Technicals
SMA
Positive
20 days / 200 days
Momentum
-13.88%
12-Months-Change
Fundamentals
Return on Equity
-261.18%
Trailing 12-Months
Asset Growth
15.64%
Trailing 12-Months
Company Description
Establishment Labs Holdings Inc
Establishment Labs Holdings Inc., a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under Motiva Implants brand name. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander, as well as distributes Puregraft line of products for autologous adipose tissue harvesting and redistribution. The company sells its products through exclusive distributors and direct sales force in Europe, Latin America, the Asia-Pacific, and internationally. Establishment Labs Holdings Inc. was incorporated in 2004 and is headquartered in Alajuela, Costa Rica.
ESTA Earnings Call
Q2 2025
0:00 / 0:00
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook with strong revenue growth and successful market penetration in the U.S. and Europe. However, challenges in the Chinese market and increased operating expenses present some concerns.View all ESTA earnings summariesESTA Stock 12 Month Forecast
Average Price Target
$55.13
▲(41.03% Upside)
Technical Analysis
Ownership Overview
20.05% Insiders
18.12% Mutual Funds
0.54% Other Institutional Investors
60.64% Public Companies and
Individual Investors